Thomson Rachel, Donnan Ellen, Konstantinos Anastasios
1 Gallipoli Medical Research Centre, Greenslopes Private Hospital.
2 Metro South Clinical TB Service, Princess Alexandra Hospital.
Ann Am Thorac Soc. 2017 Mar;14(3):318-323. doi: 10.1513/AnnalsATS.201612-994OI.
In Queensland, Australia, all cases of mycobacterial infection (tuberculosis [TB] and nontuberculous mycobacteria [NTM]) are notifiable under the Queensland Public Health Act (2005). This process originally emerged to avoid NTM confounding with notification of cases of TB, but has facilitated awareness of the increasing incidence and changing epidemiology of NTM. Although initially not a public health priority, the notification process has facilitated research that has led to an appreciation of both public health and environmental health issues associated with these pathogens. When reports of NTM infections were low in frequency, reporting was managed largely by clinicians specializing in TB. However, as reports of NTM isolates surpassed those for TB, the workload associated with clinical reporting exceeded resources. The Communicable Diseases Branch transitioned to digital reporting of laboratory isolates of mycobacteria, thereby enabling weekly and quarterly reporting of data, and generation of more detailed annual reports. The reports now include species and geographic distributions by health service district, allowing identification of clusters requiring further investigation and systematic reviews of different species. With ecological and climate change, the distribution and virulence of these emerging pathogens are evolving. Evidence of transmission of highly virulent and antibiotic-resistant clones of Mycobacterium abscessus among patients with cystic fibrosis internationally heightens the need for timely reporting to public health authorities. Ongoing systematic monitoring by public health authorities will be crucial to our understanding of NTM diseases.
在澳大利亚昆士兰州,根据《昆士兰公共卫生法》(2005年),所有分枝杆菌感染病例(结核病[TB]和非结核分枝杆菌[NTM])均须通报。这一过程最初是为了避免非结核分枝杆菌与结核病病例通报相混淆,但却有助于提高对非结核分枝杆菌发病率上升和流行病学变化的认识。尽管最初并非公共卫生优先事项,但通报过程促进了相关研究,使人们认识到与这些病原体相关的公共卫生和环境卫生问题。当非结核分枝杆菌感染报告频率较低时,报告工作主要由结核病专科临床医生负责。然而,随着非结核分枝杆菌分离株报告超过结核病报告,临床报告相关工作量超出了资源承受能力。传染病部门转而采用分枝杆菌实验室分离株的数字报告方式,从而能够每周和每季度报告数据,并生成更详细的年度报告。现在的报告包括按卫生服务区划分的菌种和地理分布,有助于识别需要进一步调查的聚集性病例以及对不同菌种进行系统综述。随着生态和气候变化,这些新出现病原体的分布和毒力正在演变。国际上有证据表明,脓肿分枝杆菌的高毒力和耐抗生素克隆在囊性纤维化患者中传播,这凸显了及时向公共卫生当局报告的必要性。公共卫生当局持续进行系统监测对于我们了解非结核分枝杆菌疾病至关重要。